With his diagnosis, the president became the living embodiment of how experimental medical interventions have entered the political spotlight. Right to Try proponents argue that it is necessary as it removes the FDA from the process of approving requests for access to experimental interventions. But while 21 of the expanded access campaigns reported being approved to access treatment via this pathway, only one Right to Try campaign did so. These campaigns tended to treat the “Right to Try” as shorthand for wanting and deserving to access experimental interventions. In this vein, several campaigns read like political statements, expressing support for President Trump for signing the Right to Try law.